🕵️ Silence Therapeutics PLC ($SLNCF)
SEC insider & ownership activity, last 12 months · CIK 1479615 · every row links its SEC filing
Over the last 12 months insiders sold in 1 filings whose value could not be assessed. Richard Griffiths trimmed 21.7% → 8.0%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $0 (19 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Richard Ian Griffiths | 0 | – | 19 | – | Aug 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ORA Capital Limited | 13.5% | 13D | Jul 6, 2026 | filing ↗ | |
| Richard Griffiths | 8.0% | 13D | Aug 12, 2026 | filing ↗ | |
| Raymond Debbane | 7.0% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Public Equities, L.P. | 6.1% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 6.1% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Global Management, LLC | 6.1% | 13G | Aug 13, 2026 | filing ↗ | |
| Siren, L.L.C. | 6.1% | 13G | Aug 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Material agreement (1.01) | May 18, 2026 | filing ↗ |
| Agreement terminated (1.02) | May 18, 2026 | filing ↗ |
| Other events (8.01) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 14, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 14, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |